Membership is FREE – with unlimited access to all features, tools, and discussions. Premium accounts get benefits like banner ads and newsletter exposure. ✅ Signature links are now free for all. 🚫 No AI-generated (LLM) posts allowed. Share your own thoughts and experience — accounts may be terminated for violations.

Diabetes - SF-1019 Receives Approval For Treatment, Marketing And Distribution In Mal

Status
Not open for further replies.

Adam DickerAdam Dicker is verified member.

New Member
The Originals
Legacy Exclusive Member
Domain Broker
Joined
Feb 20, 2003
Messages
15,041
Reaction score
1,192
Immunosyn Corporation (OTCBB:IMYN) announced today that marketing, distribution and patient treatment approval has been granted by the Ministry of Health Malaysia for SF-1019 in the Private Pay Heath Sector in Malaysia. The marketing name for SF-1019 in Malaysia will be R-1818.

More...
 

davidwest

New Member
Legacy Platinum Member
Joined
Dec 26, 2007
Messages
129
Reaction score
0
nice tip...

very interesting, especially the " SF-1019 was developed from extensive research into Biological Response Modifiers (BRMs)..." quote.

a concept that could really change medicine...

thanks
d
 
Status
Not open for further replies.
Top Bottom